The 340B Drug Pricing Playbook, With Brandon Shirley Krieg DeVault Podcast Series podcast

Over 20 million podcasts, powered by

Content provided by Krieg DeVault. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Krieg DeVault or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.

Krieg DeVault Podcast Series »
The 340B Drug Pricing Playbook, with Brandon Shirley

10d ago 19:27

MP3•Episode home

Clients have asked Brandon Shirley about acquiring a health entity that would qualify for the 340B Drug Pricing Program because, as he explains, “it does enable substantial benefits if you can get into it.” But the program is also complex. A healthcare Senior Counsel at Krieg DeVault, Brandon dissects 340B, which requires drug manufacturers to provide upfront discounts to eligible healthcare entities serving uninsured and low-income populations. With host George Lepeniotis, he clarifies who qualifies as a "covered entity," explains the disputes over patient eligibility definitions, and addresses the controversial manufacturer-proposed "rebate model".

Connect and Learn More

☑️ Brandon Shirley | LinkedIn

☑️ Krieg DeVault

☑️ George Lepeniotis | LinkedIn

☑️ Krieg DeVault | LinkedIn | X | Facebook

☑️ Subscribe Apple Podcasts | Spotify | Amazon Music

35 episodes

#Krieg DeVault